Following 2021’s expansive investments and the decrease in funding in 2022, alongside significant layoffs, stakeholders expect funders to be more selective in 2023 – scrutinizing companies’ business models and considering whether they’ve demonstrated they can improve patient outcomes, reports Mobi Health News.
Eight executives in the space share their perspectives on what the New Year will bring in terms of capital needs. Read more.
